Skip to content Skip to footer

A Clinical Development Partner for Growing Biotech Companies

Gaea works alongside biotech and pharmaceutical innovators to help bring promising therapies closer to patients. We combine decades of international clinical development experience with a flexible, collaborative approach that adapts to the needs of each programme.

Rather than simply delivering services faster than many, we can become part of your team, providing strategic guidance, operational expertise, and local knowledge across all of Europe and beyond. From early planning through study execution, we focus on building trusted partnerships that support informed decisions, efficient delivery, and long-term success.

Experienced. FocusedCollaborative.

Services

Clinical Project Management

Clinical Project Management

Look more

Enabling Technologies

Enabling Technologies

Look more

Site Feasibility and Selection

Site Feasibility and Selection

Look more

Nigel Goodman

CEO at Gaea OÜ

I am passionate about helping innovative therapies for serious diseases with unmet medical needs reach patients as efficiently as possible. Throughout my career, I have worked with sponsors ranging from emerging biotechs and virtual companies to established pharmaceutical organisations, supporting programmes from early planning and clinical strategy through to study execution and delivery.

At Gaea, we believe that successful clinical development is built on partnership. Many biotech companies have limited internal clinical operations resources or limited experience running international clinical trials. We work as an extension of our clients’ teams, providing practical guidance, strategic input, operational expertise, and hands-on support from the earliest stages of development. Our goal is not simply to deliver a study, but to help sponsors make informed decisions, manage risk, and answer critical clinical questions as quickly and effectively as possible.

I do not believe that the largest CROs are always the most effective solution. Large organisations have significant overheads and necessarily rely on standardised processes and risk-based approaches at scale. In contrast, Gaea offers senior-level involvement, direct communication, and a highly personalised approach. Clinical trials are ultimately delivered by dedicated people at busy research sites who are balancing research with patient care. We believe strong relationships, practical support, and a deep understanding of local realities remain essential to trial success.

Beyond business, I believe companies have a responsibility to contribute positively to the wider world. Sustainability is a core value for both me and Gaea, whether through responsible business practices, environmental stewardship, or supporting initiatives that strengthen our communities. I am proud to support educational and conservation projects in Kenya and humanitarian efforts supporting Ukraine and its people. Building a successful business should go hand in hand with making a positive contribution to society and to the only planet we all share.

Ukrainian patients need clinical research access more even than before and with the incredible engagement of research teams, we can perform clinical trials with fast patient recruitment, and minimum drop-out rates. To help us:  on 22nd March 2023 the UA Competent Authority reduced an expert evaluation of a clinical trial application from 47 working days to 30 calendar days and shortened the approval timeline from 5 working days to 5 calendar days, a very significant reduction in time to launch your trial in Ukraine. (MoH order No 190 of 31st of January 2023).

Leave a request or contact us in any convenient way for you.